PLUS1
2.72
0.06 (2.26%)
0.06 (2.26%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 402,356 |
|
|||||
| News | - | ||||||
| Day High | 2.8799 | Low High |
|||||
| Day Low | 2.54 | ||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| 180 Life Sciences Corporation | ATNF | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| 0.06 | 2.26% | 2.72 | 19:38:30 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.62 | 2.54 | 2.8799 | 2.56 | 2.66 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,467 | 402,356 | $ 2.68 | $ 1,077,826 | - | 2.25 - 13.0453 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:17:07 | formt | 200 | $ 2.72 | USD |
Period:
Draw Mode:
180 Life Sciences Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 66.37M | 24.40M | 29.99M | $ - | $ - | -0.66 | -1.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 893.69k | 12.20% |
180 Life Sciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ATNF Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.87 | 2.9799 | 2.25 | 2.59 | 488,609 | -0.15 | -5.23% |
| 1 Month | 3.68 | 4.09 | 2.25 | 3.15 | 460,212 | -0.96 | -26.09% |
| 3 Months | 5.05 | 6.96 | 2.25 | 4.32 | 1,050,979 | -2.33 | -46.14% |
| 6 Months | 8.35 | 8.90 | 2.25 | 5.12 | 856,747 | -5.63 | -67.43% |
| 1 Year | 3.50 | 13.0453 | 2.25 | 7.07 | 1,285,030 | -0.78 | -22.29% |
| 3 Years | 10.23 | 13.0453 | 1.90 | 6.40 | 737,244 | -7.51 | -73.41% |
| 5 Years | 9.70 | 13.0453 | 1.90 | 6.47 | 558,276 | -6.98 | -71.96% |
180 Life Sciences Description
| 180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics. |
